PROS1 variant c.1574C>T p.Ala525Val causes portal vein thrombosis with protein S deficiency.


Journal

Clinics and research in hepatology and gastroenterology
ISSN: 2210-741X
Titre abrégé: Clin Res Hepatol Gastroenterol
Pays: France
ID NLM: 101553659

Informations de publication

Date de publication:
05 2023
Historique:
received: 12 04 2023
revised: 12 05 2023
accepted: 15 05 2023
medline: 5 6 2023
pubmed: 20 5 2023
entrez: 19 5 2023
Statut: ppublish

Résumé

Protein S (PS) is a vitamin K-dependent plasma glycoprotein, and the deficiency of PS increases the risk of venous thromboembolism (VTE). PS deficiency has been found in 1.5-7% of selected groups of thrombophilic patients. However, the reported PS deficiency patients with portal vein thrombosis are scarce. Our case described a 60-year-old male patient presented portal vein thrombosis with protein S deficiency. Imaging findings of the patient revealed extensive thrombosis involving the portal vein and superior mesenteric vein. His medical history revealed lower extremity venous thrombosis 10 years ago. The level of PS activity was greatly reduced (14%, reference: 55-130%). Acquired thrombophilia caused by antiphospholipid syndrome, hyperhomocysteinemia, or malignancy were excluded. Whole exome sequencing revealed a heterozygous missense variation c.1574C>T, p.Ala525Val in the PROS1 gene. The in-silico analysis of the variant was performed by SIFT and PolyPhen-2. The results showed that the variant is a pathogenic and likely pathogenic variation respectively (SIFT, -3.404; PolyPhen-2, 0.892), the amino acid substitution A525V is presumed to result in unstable PS protein which is degraded intracellularly. Mutation site of the proband and his family members was validated by Sanger sequencing. According to the clinical manifestation, imaging findings, protein S level, and the genetic results, a diagnosis of portal vein thrombosis with PS deficiency was made. To the best of our knowledge, our case is the second reported PS deficiency patient caused by PROS1 c.1574C>T, p.Ala525Val variant in Asia, and the case is also the only reported case with PROS1 c.1574C>T, p.Ala525Val variant presents portal vein thrombosis.

Sections du résumé

BACKGROUND
Protein S (PS) is a vitamin K-dependent plasma glycoprotein, and the deficiency of PS increases the risk of venous thromboembolism (VTE). PS deficiency has been found in 1.5-7% of selected groups of thrombophilic patients. However, the reported PS deficiency patients with portal vein thrombosis are scarce.
CASE REPORT AND RESULTS
Our case described a 60-year-old male patient presented portal vein thrombosis with protein S deficiency. Imaging findings of the patient revealed extensive thrombosis involving the portal vein and superior mesenteric vein. His medical history revealed lower extremity venous thrombosis 10 years ago. The level of PS activity was greatly reduced (14%, reference: 55-130%). Acquired thrombophilia caused by antiphospholipid syndrome, hyperhomocysteinemia, or malignancy were excluded. Whole exome sequencing revealed a heterozygous missense variation c.1574C>T, p.Ala525Val in the PROS1 gene. The in-silico analysis of the variant was performed by SIFT and PolyPhen-2. The results showed that the variant is a pathogenic and likely pathogenic variation respectively (SIFT, -3.404; PolyPhen-2, 0.892), the amino acid substitution A525V is presumed to result in unstable PS protein which is degraded intracellularly. Mutation site of the proband and his family members was validated by Sanger sequencing.
CONCLUSION
According to the clinical manifestation, imaging findings, protein S level, and the genetic results, a diagnosis of portal vein thrombosis with PS deficiency was made. To the best of our knowledge, our case is the second reported PS deficiency patient caused by PROS1 c.1574C>T, p.Ala525Val variant in Asia, and the case is also the only reported case with PROS1 c.1574C>T, p.Ala525Val variant presents portal vein thrombosis.

Identifiants

pubmed: 37207893
pii: S2210-7401(23)00066-9
doi: 10.1016/j.clinre.2023.102141
pii:
doi:

Substances chimiques

Blood Proteins 0
PROS1 protein, human 0
Protein S 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

102141

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no competing interests.

Auteurs

Xiaoying Ye (X)

Hangzhou Normal University, Zhejiang, China.

Xiaoxiao Mi (X)

Institute of Translational Medicine, Hangzhou Normal University Affiliated Hospital, Zhejiang, China.

Jiawei Sun (J)

Hangzhou Normal University, Zhejiang, China.

Yiling ShenTu (Y)

Department of Respiratory Medicine, Fuyang First People's Hospital, Hangzhou, China.

Yingming Fei (Y)

Department of Infectious Disease (Liver Diseases), Shaoxing University Affiliated Hospital, Zhejiang, China.

Dong Tang (D)

Department of Medical Imaging (Radiology), Hangzhou Normal University Affiliated Hospital, Zhejiang, China.

Xiaoping Ye (X)

Department of Infectious Disease (Liver Diseases), Hangzhou Normal University Affiliated Hospital, Zhejiang, China.

Xiaojie Ma (X)

Department of Infectious Disease (Liver Diseases), Hangzhou Normal University Affiliated Hospital, Zhejiang, China.

Junping Shi (J)

Department of Infectious Disease (Liver Diseases), Hangzhou Normal University Affiliated Hospital, Zhejiang, China.

Gongying Chen (G)

Department of Infectious Disease (Liver Diseases), Hangzhou Normal University Affiliated Hospital, Zhejiang, China.

Ling Gong (L)

Department of Infectious Disease (Liver Diseases), Hangzhou Normal University Affiliated Hospital, Zhejiang, China. Electronic address: gongllyy22@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH